首页> 外文期刊>Neuroscience: An International Journal under the Editorial Direction of IBRO >D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens.
【24h】

D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens.

机译:D1和D2多巴胺受体介导苯丙胺诱导伏隔核中乙酰胆碱的释放。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

To assess the interaction of dopamine and acetylcholine systems in the rat nucleus accumbens in response to direct D-amphetamine administration, in vivo microdialysis measures of acetylcholine were used during reverse dialysis of amphetamine alone and in combination with D1 and D2 receptor antagonists SCH 23390 and sulpiride, respectively. During a 15-min exposure to amphetamine (50 microM) in the nucleus accumbens, acetylcholine increased to 33% above pre-infusion levels, became maximal at 15 min post-infusion (+41%) and gradually returned to baseline levels by 60 min post-amphetamine. Conversely, amphetamine (1 mM) administration caused a biphasic change in acetylcholine release with a trend toward a decrease (-14%) during exposure followed by a significant increase (+36%) at 30 min post-amphetamine that returned to baseline levels by 60 min after infusion. The increases observed during amphetamine (50 microM) exposure and during recovery from amphetamine (1 mM) were both blocked by co-administration with the D1 antagonist, SCH 23390 (10 microM), but not with the D2 antagonist, sulpiride (10 microM). Co-infusion of sulpiride eliminated the trend toward reduced acetylcholine release observed during 1 mM amphetamine whereas co-administration of SCH 23390 potentiated this decrease. A possible tonic D1 facilitation of nucleus accumbens acetylcholine release was indicated by the consistent reductions in acetylcholine release observed during infusion of SCH 23390. These results suggest that amphetamine administration in the nucleus accumbens induces a bidirectional change in acetylcholine release that is dependent on dose and opposing effects of nucleus accumbens D1 and D2 activation. In general, relatively low doses of amphetamine administered into the nucleus accumbens caused an increase in acetylcholine release that was dependent on dopamine D1 receptors whereas higher doses of amphetamine resulted in a D2-mediated decrease.
机译:为了评估直接给予D-苯丙胺后大鼠伏隔核中多巴胺和乙酰胆碱系统的相互作用,在苯丙胺单独透析以及与D1和D2受体拮抗剂SCH 23390和舒必利联合使用时,对乙酰胆碱进行体内微透析测量, 分别。在伏伏核中暴露于安非他明(50 microM)15分钟期间,乙酰胆碱增加至输注前水平的33%,在输注后15分钟时达到最大值(+ 41%),并在60分钟后逐渐恢复至基线水平苯丙胺后。相反,安非他明(1 mM)给药会导致乙酰胆碱释放发生双相变化,并在暴露过程中呈下降趋势(-14%),然后在苯丙胺后30分钟时显着增加(+ 36%),并恢复到基线水平。输注后60分钟。与D1拮抗剂SCH 23390(10 microM)并用,但与D2拮抗剂舒必利(10 microM)并用时,苯丙胺(50 microM)暴露期间和从苯丙胺恢复(1 mM)期间观察到的增加均被阻止。 。舒必利的共同输注消除了在1 mM苯丙胺期间观察到的乙酰胆碱释放减少的趋势,而SCH 23390的共同给药则增强了这种减少的趋势。 SCH 23390输注过程中观察到的乙酰胆碱释放的持续降低表明,伏隔核可能促进伏隔核的乙酰胆碱释放。这些结果表明,伏伏核给予苯丙胺会引起乙酰胆碱的双向释放变化,这取决于剂量和相反的情况。伏伏核D1和D2激活的影响。通常,向伏隔核中给予相对较低剂量的苯丙胺会导致乙酰胆碱释放增加,这取决于多巴胺D1受体,而较高剂量的苯丙胺会导致D2介导的下降。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号